Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia
Por um escritor misterioso
Descrição
October 1st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.
Rexulti Full Prescribing Information, Dosage & Side Effects
Full article: In vitro evaluations for pharmacokinetic drug-drug interactions of a novel serotonin-dopamine activity modulator, brexpiprazole
Full article: In vitro evaluations for pharmacokinetic drug-drug interactions of a novel serotonin-dopamine activity modulator, brexpiprazole
Table 2 from Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.
ex9902004.jpg
Introduction - Clinical Review Report: Brexpiprazole (Rexulti) - NCBI Bookshelf
Rexulti 1 Mg, Antipsychotic - 28 Tablets
Brexpiprazole: A Newly Approved Atypical Antipsychotic Agent
Full article: Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human
ex99-01_img005.jpg
ex9901_img005.jpg
Buy Rexulti Online at Lower Price From
1mg REXULTI TABLET, Schizophrenia, Intas Pharmaceuticals
FDA Approves New Schizophrenia, Depression Drug Brexpiprazole - Psychiatry Advisor
PDF) Construction and evaluation of a phospholipid-based phase transition in situ gel system for brexpiprazole
de
por adulto (o preço varia de acordo com o tamanho do grupo)
